GlassScriptPhysician profile
Bradley W Warner
NPI 1417100405
$7,723.02
in general payments reported to CMS, 2019-2025
39 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,446 · 2020: $494 · 2021: $3.82 · 2022: $1,344 · 2023: $1,672 · 2024: $2,763.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,071 · Travel and Lodging: $1,264 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,070.96 |
| Travel and Lodging | $1,263.97 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,367.76 | 2024 | Aquabeam System |
| Boston Scientific Corporation | $1,243.91 | 2019-2024 | Rezum Generator, Spaceoar Vue System - 10ml, Moses 550 Dfl |
| Astellas Pharma US INC | $1,102.87 | 2019-2024 | Myrbetriq, Xtandi, Veozah |
| Janssen Biotech, INC. | $606.07 | 2019-2024 | Erleada |
| Abbvie INC. | $531.22 | 2019-2024 | Botox, Lupron Depot |
| Sumitomo Pharma America, INC. | $529.65 | 2023-2024 | Gemtesa, Orgovyx |
| Dendreon Pharmaceuticals LLC | $329.21 | 2019-2024 | Provenge |
| Rochester Medical Corporation | $212.77 | 2019-2022 | |
| Pfizer INC. | $209.26 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $192.95 | 2023-2024 | Lynparza |
| Bayer Healthcare Pharmaceuticals INC. | $146.13 | 2019-2024 | |
| Allergan, INC. | $114.18 | 2019-2020 | |
| Tolmar, INC. | $110.91 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $108.72 | 2023-2024 | Lynparza, Keytruda |
| Sun Pharmaceutical Industries INC. | $97.00 | 2019-2024 | Yonsa |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Accord Healthcare, INC. | $87.18 | 2023-2024 | |
| Urogen Pharma, INC. | $74.61 | 2022-2024 | Jelmyto |
| Ferring Pharmaceuticals INC. | $72.59 | 2019-2024 | Adstiladrin |
| Verity Pharmaceuticals INC. | $69.60 | 2023-2024 | Trelstar |
| Coloplast Corp | $51.31 | 2019-2020 | |
| Antares Pharma, INC. | $42.00 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $41.41 | 2019-2020 | |
| Amgen INC. | $38.41 | 2022-2023 | Xgeva |
| Endo Pharmaceuticals INC. | $38.08 | 2019-2020 | |
| Cook Medical LLC | $37.58 | 2020-2024 | Cook |
| Smith+Nephew, INC. | $32.08 | 2022 | |
| 180 Medical, INC. | $27.81 | 2023 | Cure Catheter |
| Agiliti Surgical, INC. | $24.58 | 2019 | |
| Laborie Medical Technologies Corp. | $23.21 | 2023 | |
| Novartis Pharmaceuticals Corporation | $22.15 | 2024 | |
| Novo Nordisk INC | $20.51 | 2024 | |
| Immunitybio, INC. | $18.42 | 2024 | |
| Baxter Healthcare | $17.60 | 2023 | Tisseel |
| Edap Technomed INC | $17.10 | 2023 | |
| Medtronic USA, INC. | $15.00 | 2019 | |
| Innovation Technologies INC | $14.31 | 2023 | Irrisept |
| Tempus Ai, INC | $14.11 | 2024 | |
| Axonics, INC. | $13.12 | 2023 | Axonics, Bulkamid |
| Travere Therapeutics, INC. | $7.64 | 2020-2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Warner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.